A Pilot Study for the Treatment of Patients With Metastatic and High Risk Sarcomas and Primitive Neuroectodermal Tumors

NCT00001209 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

120

Enrollment

NIH

Sponsor class

Conditions

Neuroectodermal Tumor, Primitive
Neuroepithelioma
Osteosarcoma
Sarcoma
Sarcoma, Ewing's

Interventions

DRUG: vincristine, adriamycin and cytoxan, alternating with ifosfamide VP-16

Sponsor

National Cancer Institute (NCI)